Significant Ownership of Commodore Capital LP

Signature - Title
Michael Kramarz - Managing Partner
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Commodore Capital LP.

Follow Filing Activity

Follow Commodore Capital LP and return when a new Schedule 13D/G filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Significant Ownership of Commodore Capital LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ELVN Enliven Therapeutics, Inc. Common Stock, par value $0.001 per share 9.9% $135,215,385 6,022,957 Commodore Capital LP 30 Jun 2025
RLAY Relay Therapeutics, Inc. Common Stock, par value $0.0001 per share 9.9% $88,740,000 +$19,053,000 17,000,000 +27% Commodore Capital LP 30 Sep 2025
ANRO Alto Neuroscience, Inc. Common Stock, $0.0001 par value per share 9.9% $53,552,862 +$913,456 3,245,628 +1.7% Commodore Capital LP 31 Dec 2025
CATX Perspective Therapeutics, Inc. Common Stock, $0.001 par value 9.9% $29,968,780 11,939,753 Commodore Capital LP 02 Feb 2026
ASMB ASSEMBLY BIOSCIENCES, INC. Common Stock, par value $0.001 9.9% $29,281,576 1,615,981 Commodore Capital LP 08 Aug 2025
SABS SAB BIOTHERAPEUTICS, INC. Common Stock, $0.0001 par value per share 9.9% $9,588,711 4,522,977 Commodore Capital LP 26 Sep 2025
IMUX IMMUNIC, INC. Common Stock, par value $0.0001 9.9% $8,143,574 13,350,121 Commodore Capital LP 17 Feb 2026
PALI PALISADE BIO, INC. Common Stock, par value $0.01 per share 9.9% $5,620,586 9,690,665 Commodore Capital LP 01 Oct 2025
ANTX AN2 Therapeutics, Inc. Common Stock, par value $0.00001 per share 9.9% $4,880,614 3,697,435 Commodore Capital LP 09 Mar 2026
VTGN Vistagen Therapeutics, Inc. Common Stock, par value $0.001 per share 9.9% $3,243,796 4,383,508 Commodore Capital LP 31 Dec 2025
KPTI Karyopharm Therapeutics Inc. Common Stock, $0.0001 par value 9.9% $1,170,000 1,950,000 Commodore Capital LP 26 Mar 2026
Definium Therapeutics, Inc. Common Shares, no par value per share 7.2% 7,428,775 Commodore Capital LP 31 Dec 2025
IPSC Century Therapeutics, Inc. Common Stock, par value $0.0001 per share 7.1% $12,354,782 13,043,478 Commodore Capital LP 09 Jan 2026
TYRA Tyra Biosciences, Inc. Common Stock, $0.0001 par value per share 6.3% $47,216,250 +$8,743,750 3,375,000 +23% Commodore Capital LP 30 Sep 2025
LB PHARMACEUTICALS INC Common Stock, $0.0001 par value per share 5.5% 1,225,000 Commodore Capital LP 11 Sep 2025
AMLX Amylyx Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share 5.1% $89,213,500 5,650,000 Commodore Capital LP 10 Nov 2025
PEPG PepGen Inc. Common stock, par value $0.0001 per share 5.1% $16,550,952 3,544,101 Commodore Capital LP 04 Mar 2026
NRIX Nurix Therapeutics, Inc. Common Stock, par value $0.001 per share 4.9% $34,927,708 -$646,292 3,780,055 -1.8% Commodore Capital LP 30 Sep 2025
MRUS Merus N.V. Common Shares, (euro) 0.09 nominal value per share 4.7% $192,112,500 -$12,262,500 3,525,000 -6% Commodore Capital LP 30 Jun 2025
CLDX Celldex Therapeutics, Inc. Common Stock, par value $.001 4.6% $78,343,026 -$8,321,474 3,028,335 -9.6% Commodore Capital LP 30 Sep 2025
VRDN Viridian Therapeutics, Inc.\DE Common Stock, $0.01 par value 3.9% $69,056,000 -$23,738,000 3,200,000 -26% Commodore Capital LP 30 Sep 2025
NGNE Neurogene Inc. Common Stock, $0.000001 par value 3% $9,169,168 427,866 Commodore Capital LP 30 Jun 2025
CELC Celcuity Inc. Common Stock, $0.001 par value per share 2.9% $12,095,976 1,095,650 COMMODORE CAPITAL LP 31 Dec 2024
CDTX Cidara Therapeutics, Inc. Common Stock, par value $0.0001 per share 2% $56,019,600 -$56,498,400 585,000 -50% Commodore Capital LP 30 Sep 2025
COGT Cogent Biosciences, Inc. Common Stock, $0.001 par value per share 1.8% $99,699,331 -$263,401,363 2,802,905 -73% Commodore Capital LP 31 Dec 2025
TERN Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share 1.4% $52,333,000 -$149,903,000 1,475,000 -74% Commodore Capital LP 31 Dec 2025
NKTX Nkarta, Inc. Common Stock, $0.0001 par value per share 0.5% $742,399 351,848 COMMODORE CAPITAL LP 31 Dec 2024
DRUG BRIGHT MINDS BIOSCIENCES INC. Common Shares, without par value 0.3% $1,685,468 -$43,019,532 18,851 -96% Commodore Capital LP 31 Dec 2025
PCSC Perceptive Capital Solutions Corp Class A Ordinary Shares, par value $0.0001 per share 0% $0 0 Commodore Capital LP 31 Dec 2025
SLDB Solid Biosciences Inc. Common Stock $0.001 par value per share 0% $0 -$31,571,500 0 -100% Commodore Capital LP 30 Jun 2025
CRDF Cardiff Oncology, Inc. Common Stock 0% $0 -$21,915,387 0 -100% Commodore Capital LP 30 Jun 2025

Schedules 13D/G Reported by Commodore Capital LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored